Evidence map›Paper›PMID 36439583›Full record

ArticleCureus2022

Adherence to Diabetes Mellitus Treatment Regimen Among Patients With Diabetes in the Tabuk Region of Saudi Arabia.

Mansuor Alanazi, Amirah M Alatawi

Abstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mansuor AlanaziFamily and Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk, SAU.
Amirah M AlatawiFamily and Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Diabetes Mellitus (DM) types 1 and 2 and their complications are becoming more prevalent in Saudi Arabia. Non-adherence to diabetes management techniques could result in inadequate blood sugar management causing treatment failure, the rapid development of comorbidities, and higher mortality in patients with diabetes. Objectives This study investigated the adherence of patients with diabetes in the Tabuk region of Saudi Arabia to their prescribed medications and examined the association between adherence and other sociodemographic characteristics. Methods This cross-sectional study was conducted in Tabuk, Saudi Arabia, among patients with diabetes. A validated online self-administered questionnaire was provided to the research participants using Google Forms. Participants were selected using a convenient non-probability sampling method. The chi-square test was used to compare qualitative data whereas quantitative data were expressed as frequency and percentage. Results Overall, 380 participants were enrolled in this study. The study population's average diabetes treatment adherence score was 9.6 ± 3.3% from a maximum score of 15 (range: 0-15). Overall, 293 (77.1%) participants were adherent, whereas 87 (22.9%) were non-adherent. In addition, more than one-third of the individuals did not miss medication doses or follow-up appointments. However, forgetfulness was the most common cause of missed medicine doses and follow-up appointments. In addition, several sociodemographic characteristics, including marital status, nationality, geographic region, and employment position, were significantly associated with DM treatment adherence (

Indexed as

blood sugar managementdiabetes complicationsdiabetes mellitusdiabetes treatmentpatient adherencetabuk region

Identifiers

PMID36439583
PMCPMC9692058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.